The SensiTox B. anthracis Toxin Test
Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples. 510(k) K232545, from First Light Diagnostics, Inc. (Chelmsford, MA). Product code QUU, class 2.
As of Nov 20, 2026, K232545 is an FDA 510(k) held by First Light Diagnostics, Inc., substantially equivalent on Nov 20, 2023 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
The SensiTox B. anthracis Toxin Test for use with the MultiPath Analyzer, is a qualitative immunofluorescence assay to aid in the diagnosis of inhalation anthrax. The test is intended for the rapid, qualitative detection of lethal factor, a biomarker associated with Bacillus anthracis (B. anthracis).
- Active Anthrax DetectTM Plus Rapid TestDEN220044 · InBios International, Inc. · Feb 3, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 22, 2023
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3046
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files